Harlan Robins Insider Trades & Stock Holdings

Chief Scientific Officer · Adaptive Biotechnologies Corporation · Latest filing Jun 16, 2026

Harlan Robins, Chief Scientific Officer at Adaptive Biotechnologies Corporation has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($110.94K), net -$110.94K. Latest filing: disposed of 6.16K shares of $ADPT on Jun 16, 2026 at $18.01.

Trades on file

1

Open-market bought

$0

Open-market sold

$110.94K

Net open-market

-$110.94K

Latest filing

Jun 16, 2026

All insider trades by Harlan Robins

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$ADPT	Sell (Open-market sale) 10b5-1	6.16K	$18.01	$110.94K			+0.1%	+28.3%		Chief Scientific Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Harlan Robins traded

• $ADPT

Frequently asked questions

Has Harlan Robins been buying or selling stock?

Harlan Robins has 0 open-market purchases and 1 open-market sale on file, net -$110.94K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Harlan Robins's latest insider trade?

disposed of 6.16K shares of $ADPT on Jun 16, 2026 at $18.01.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.